OVERLAND PARK, Kan. -- Medi-Flex, Inc., announced today it has entered into an agreement with Novation for the ChloraPrep One-Step line of patient preoperative skin preparation products. Novation, the supply company of VHA Inc. and the University Health-System Consortium (UHC), will add the four ChloraPrep product applicators to their contract portfolio beginning Sept. 1, 2003.
"Our agreement with Novation and their hospital customers will provide thousands of patients access to ChloraPrep," said Lyle Clayton, president and chief operating officer of Medi-Flex. "ChloraPrep can help hospitals reduce infections, save lives and significantly reduce healthcare costs."
ChloraPrep is the only FDA-approved 2 percent w/v chlorhexidine gluconate and 70 percent v/v isopropyl alcohol formulation available in the United States. Currently, the CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, published in August 2002, state a preference for a 2 percent chlorhexidine-based antiseptic solution over other antiseptic agents for preparation of the skin prior to catheter insertion and site maintenance.
Studies show that ChloraPrep is effective in killing a broad spectrum of microorganisms on the skin. ChloraPrep continues killing bacteria far longer than other commonly used skin antiseptics. A single 60-second application of ChloraPrep is persistent in killing bacteria for more than 48 hours.
ChloraPrep is available in 0.67-mL Sepp, 1.5-mL Frepp, 3.0-mL and 10.5-mL applicators.
Source:Medi-Flex, Inc.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.